# Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory

> **NCT05376124** · — · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 110 (estimated)

## Conditions studied

- Hepatitis B, Chronic
- Virus Diseases

## Interventions

- **OTHER:** original therapy
- **OTHER:** rescue therapy

## Key facts

- **NCT ID:** NCT05376124
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2023-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05376124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05376124, "Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05376124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*